Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility

Journal: Nature Communications

Published: 2020-01-07

DOI: 10.1038/s41467-019-13855-2

Affiliations: 41

Authors: 51

Go to article
Institutions Share
UCSF Department of Epidemiology and Biostatistics, United States of America (USA) 0.11
WHO International Agency for Research on Cancer (IARC), France 0.08
NIH NCI Division of Cancer Epidemiology and Genetics (DCEG), United States of America (USA) 0.06
Prosserman Centre for Health Research, U of T, Canada 0.05
Quebec Heart and Lung Institute (IUCPQ), UL, Canada 0.04
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.04
Department of Molecular and Clinical Cancer Medicine (DMCCM), University of Liverpool, United Kingdom (UK) 0.04
National Institute of Occupational Health (STAMI), Norway 0.04
MRC Integrative Epidemiology Unit (IEU), UoB, United Kingdom (UK) 0.04
Bristol Medical School: Population Health Sciences, UoB, United Kingdom (UK) 0.04
BC Cancer Agency (BCCA), PHSA, Canada 0.02
Radboud Institute for Health Sciences (RIHS), RU, Netherlands 0.02
Copenhagen University Hospital (CUH), Denmark 0.02
Bellvitge Biomedical Research Institute (IDIBELL), Spain 0.02
Cancer Epidemiology Program, UH Mānoa, United States of America (USA) 0.02
Department of Cancer Epidemiology, MOFFITT, United States of America (USA) 0.02
Department of Epidemiology, Dartmouth College, United States of America (USA) 0.02
UK Markey Cancer Center, United States of America (USA) 0.02
Dalla Lana School of Public Health (DLSPH), U of T, Canada 0.02
Centre for Heart Lung Innovation (HLI), Canada 0.02
WSU Department of Pharmaceutical Sciences, United States of America (USA) 0.02
Department of Genetic Epidemiology, University of Göttingen, Germany 0.02
Institute of Neuroscience (ION), Newcastle University, United Kingdom (UK) 0.02
Department of Thoracic Surgery, VU, United States of America (USA) 0.02
Harvard Department of Environmental Health (EH), United States of America (USA) 0.02
Department of Epidemiology and Biostatistics (EBS), ICL, United Kingdom (UK) 0.02
Princess Margaret Cancer Centre, U of T, Canada 0.02
Russian Oncological Scientific Center named after N.N.Blokhin, RAMS, Russia 0.02
Institute for Clinical and Translational Research (ICTR), BCM, United States of America (USA) 0.02
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA) 0.01
Lund University (LU), Sweden 0.01
Division of Basic Science Research, MD Anderson Cancer Center, United States of America (USA) 0.01
Department of Biostatistics, MD Anderson Cancer Center, United States of America (USA) 0.01
Ruth and Bruce Rappaport Faculty of Medicine, IIT, Israel 0.01
Clalit National Israeli Cancer Control Center (NICCC), Israel 0.01
Department of Population Health Sciences (PHS), Utah, United States of America (USA) 0.01
Skåne University Hospital in Lund, SUS, Sweden 0.01
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain 0.01
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain 0.01
Faculty of Medicine and Health Sciences, UniOvi, Spain 0.01
NIHR Bristol Biomedical Research Centre (Bristol BRC), United Kingdom (UK) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER